Skip to main content
. 2024 May 7;8(14):3840–3846. doi: 10.1182/bloodadvances.2023011458

Figure 1.

Figure 1.

Expected TTFT after adustment to age, sex, and other cofounders based on the method presented by Thomsen16for comparing 4 groups: nonvitamin D users, vitamin D supplement users, alfacalcidol users, and both alfacalcidol and vitamin D supplement users. Patients with at least 6 months of exposure are considered users.